The Truth About Research Peptide Sites in 2026: FDA Crackdown, Shutdowns & What’s Changing
Research peptide sites are disappearing fast. Learn why the FDA is targeting GLP-1 peptides like semaglutide, tirzepatide, and retatrutide, what it means for access, and what to expect next. Over the past year, something major has been happening in the peptide space—and if you’ve been following it closely, you’ve probably noticed it too. Research peptide […]
